FDA NDC Directory · JSON-LD · Markdown

Acamprosate Calcium

NDC 68462-435 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerGlenmark Pharmaceuticals Inc., USA
Marketing categoryAbbreviated NDA (generic) · App ANDA202229
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsACAMPROSATE CALCIUM (333 mg/1)
Marketing started20130716
Package count2

External sources

Source: openFDA. Public-domain (CC0).